Lung cancer clinical trials are designed to assess the safety and efficacy of new treatments for lung cancer. They are an important part of developing new therapies, as they allow researchers to monitor and control the progress of the disease in participants, while also gathering evidence of the effectiveness of tre…
Lung cancer clinical trials are designed to assess the safety and efficacy of new treatments for lung cancer. They are an important part of developing new therapies, as they allow researchers to monitor and control the progress of the disease in participants, while also gathering evidence of the effectiveness of treatments. By participating in lung cancer clinical trials, patients have the opportunity to access treatments not yet available to the general public, and help in advancing understanding of the disease and its treatments. Clinical trials are also essential in identifying new ways to improve outcomes for individuals with lung cancer.
3 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 3 articles above have been cited 3 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Lung Cancer Clinical Trials, linking to each citing work.